To recap, the group on Sept 12 announced that the percentage of the company’s shares held by public shareholders had been reduced to 9.98%, representing about 26.4 billion shares owned by over 8,000 public shareholders.
Thomson Medical Group announced that it has on Sept 19 received a letter from the Singapore Exchange (SGX) advising that is has no objection to granting the company a period of three months until Dec 10 to explore options to restore the public float and the continued trading of its shares during this period.
The approval of the SGX is subject to the company monitoring the public float and trading activity in its shares on an ongoing basis, and making an immediate request for a trading halt if there is any indication of disorderly trading.
